Keylicon Biosciences
Pre-clinicalNext-generation self-amplifying RNA platform.
Founded
2018
Focus
Drug DeliverySmall Molecules
About
Next-generation self-amplifying RNA platform.
Funding History
1Total raised: $12M
Series A$12MRA Capital ManagementFeb 15, 2023
Company Info
TypePrivate
Founded2018
LocationSan Diego, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile